Key Highlights

  • The Orlando optics maker has agreed to sell its last Chinese subsidiary, capping a pivot toward a fully NDAA-compliant, defense-focused manufacturing base just as counter-drone orders and a surging backlog reshape its revenue mix and investor appeal.
  • For its fiscal third quarter of 2026, reported May 7, LightPath posted revenue of $19.1 million, up 109% year over year, with gross profit of $7.0 million at a 36% gross margin.
  • Counter-drone spending is accelerating, and LightPath's C-UAS-linked orders suggest it is winning share in a structurally growing niche.

The Immediate Catalyst

On July 23, 2026, LightPath Technologies (NASDAQ:LPTH) said it had signed a definitive agreement to sell its Chinese subsidiary in Zhenjiang for roughly $4.5 million, payable in installments over five years, to an entity owned by the unit's incumbent local management. The transaction, expected to close within weeks, will leave LightPath with no facilities or operations in China. The divested business generated about $4.5 million in annual third-party revenue in fiscal 2025 and 2026, revenue that will now drop out of consolidated results.

The disposal arrived alongside a run of defense wins. On July 22 the company disclosed roughly $13 million in follow-on optical-assembly orders tied to a counter-unmanned-aircraft-systems (C-UAS) supplier, with deliveries expected in calendar 2027. A week earlier, on July 15, it reported an approximately $11 million follow-on infrared-camera order from a global technology customer that is shifting from germanium-based optics to LightPath's proprietary BlackDiamond materials. Together, the moves frame a deliberate repositioning: exit China, and anchor growth in secure, domestically sourced defense optics.

Why the Development Matters

The China exit is more than housekeeping. It completes LightPath's transition to what management calls a fully Western-aligned, NDAA-compliant manufacturing footprint, a status that has become a gating requirement for U.S. defense programs. That matters because China's tightening of germanium exports has squeezed the traditional feedstock for infrared optics, handing LightPath an opening to position BlackDiamond chalcogenide glass as a domestically produced substitute. By pairing a clean supply chain with vertically integrated assemblies and camera subsystems, the company is trying to climb from low-margin component sales toward higher-value defense systems. For a business long dependent on commodity lenses and telecom optics, the strategic logic is to convert geopolitical friction into a structural advantage and a defensible margin story.

Business and Market Context

LightPath, based in Orlando, Florida, designs and manufactures precision optical components, infrared optics and engineered optical assemblies. Its differentiator is BlackDiamond, a family of proprietary chalcogenide glasses that can replace germanium and other imported infrared materials in thermal-imaging systems. Through recent acquisitions, including Visimid Technologies in thermal imaging and, in January 2026, the assets of Amorphous Materials, LightPath has moved to control both the raw glass and the downstream camera electronics. The company competitively overlaps with infrared specialists and larger defense-optics suppliers, but its pitch centers on being a rare U.S.-domiciled, NDAA-compliant vertically integrated player. Management has set a five-year revenue target exceeding $300 million, well above current run-rates, underscoring the scale of the intended shift from parts vendor to imaging-solutions provider.

Financial Position

The reinvention is visible in the numbers. For its fiscal third quarter of 2026, reported May 7, LightPath posted revenue of $19.1 million, up 109% year over year, with gross profit of $7.0 million at a 36% gross margin. Adjusted EBITDA turned positive at $1.1 million, against a $1.6 million loss a year earlier, though reported results absorbed a $3.4 million earnout fair-value adjustment, and the company has continued to report GAAP net losses as it invests. The order book is the headline: backlog reached $110.6 million, up roughly 196% since June 30, 2025.

Cash stood at $55.2 million at quarter-end. Liquidity was reinforced on June 2, when LightPath priced a $100 million registered direct offering of about 7.14 million shares at $14.00; the company issued roughly 3.57 million new shares for approximately $50 million in gross proceeds, with the remainder sold by existing holders. In late June, the stock was added to the Russell 2000 and Russell 3000 indexes, broadening its investor base.

The Bull Case

The bull thesis rests on demand meeting scarcity. Counter-drone spending is accelerating, and LightPath's C-UAS-linked orders suggest it is winning share in a structurally growing niche. China's germanium curbs make a domestic infrared-glass supplier strategically valuable, and BlackDiamond gives LightPath a differentiated, supply-secure product just as customers seek alternatives. A backlog near $111 million, up nearly threefold in a year, provides unusual revenue visibility for a company this size, while positive adjusted EBITDA signals the model can scale profitably. Index inclusion and a strengthened balance sheet add support, and vertical integration into cameras points toward richer margins over time.

The Bear Case and Principal Risks

The risks are real and largely execution-driven. LightPath still reports GAAP losses, and non-cash charges such as the $3.4 million earnout adjustment cloud reported profitability. Growth has been fueled by acquisitions and equity issuance; the June offering and outstanding earnouts dilute shareholders, and integrating Visimid and Amorphous Materials while standing up new BlackDiamond manufacturing is operationally demanding. Much of the backlog converts to revenue only in 2027, so any slippage in defense procurement or program timing would bite. Customer and program concentration in a few large orders heightens volatility, and the China exit, however strategically clean, removes about $4.5 million of annual revenue. After a sharp share-price run, valuation leaves little room for disappointment, and small-cap defense suppliers remain exposed to budget cycles and lumpy order flow.

What Investors Should Watch Next

Key markers include confirmation that the Zhenjiang sale closes on the disclosed terms and timeline, and how management reframes revenue guidance once China is deconsolidated. Investors should track fiscal fourth-quarter and full-year 2026 results for gross-margin trajectory, GAAP profitability and cash burn after the June raise. Progress converting the $110.6 million backlog, particularly the 2027 C-UAS deliveries, and evidence that customers are actually migrating from germanium to BlackDiamond at volume, will test the strategic narrative. Further defense follow-on orders would reinforce it.

Conclusion

LightPath has assembled a coherent story: exit China, lean into NDAA-compliant defense optics, and monetize a proprietary alternative to constrained germanium supply. The surging backlog, positive adjusted EBITDA and fresh capital lend the pivot credibility, and the timing aligns with genuine tailwinds in counter-drone and secure-supply-chain demand. Yet the company must still prove it can convert orders into GAAP profits, integrate acquisitions and justify a valuation that already reflects considerable optimism. The next several quarters, spanning the China closing and 2027 deliveries, will show whether the repositioning translates into durable earnings or merely a well-marketed transition.

This article is for informational purposes only and does not constitute investment advice or a recommendation to buy, sell, or hold any security. Share prices can rise or fall, and past performance does not guarantee future results. Investors should conduct independent research and consult a licensed financial adviser before making investment decisions.